Ann Rehabil Med.  2011 Jun;35(3):432-435. 10.5535/arm.2011.35.3.432.

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate: A Case Report

• Seok H
• Kim YT
• Kim SH
• Cha JG

• KMID: 2266865
• DOI: http://doi.org/10.5535/arm.2011.35.3.432

Abstract

Transient osteoporosis of the hip (TOH) is a rare disorder of unknown etiology that is characterized by acute onset of disabling bone pain. The locally increased bone turnover and low bone mineral density (BMD) associated with this disorder indicate a potential role for an antiresorptive agent such as bisphosphonate as a treatment. A previously healthy 46-year-old man developed the sudden onset of pain in his right buttock and inguinal area, especially during walking and caused him to limp. A thorough medical workup including X-ray, MRI, and bone SPECT revealed transient osteoporosis of the hip, and he was treated with an infusion of zoledronate (5 mg). Two weeks later, he was fully recovered from pain and the gait disturbance. A follow-up MRI of the hip joint taken after 6 months showed complete resolution. The use of intravenous zoledronate provided a successful outcome in the treatment of TOH. The possibility of TOH should be considered in patients complaining of sudden hip pain and a limping gait. MR imaging played an important role for differentiation of TOH from other aggressive conditions with long term sequelae.

Keyword

Transient osteoporosis of hip (TOH); Bisphosphonate

MeSH Terms

Bone Density
Buttocks
Diphosphonates
Follow-Up Studies
Gait
Hip
Hip Joint
Humans
Imidazoles
Middle Aged
Osteoporosis
Tomography, Emission-Computed, Single-Photon
Walking
Diphosphonates
Imidazoles

Figure

• 

  Fig. 1 (A) The coronal T1 weighted image of hip joint shows patchy low signal intensity lesion in right femoral head (arrow), (B) which demonstrates high signal intensity lesion on fat suppressed coronal T2 weighted image (arrow).

• 

  Fig. 2 Follow-up hip MRI showed no abnormal lesion in both femoral heads.

Reference

1. Korompilias AV, Karantanas AH, Lykissas MG, Beris AE. Bone marrow edema syndrome. Skeletal Radiol. 2009; 38:425–436. PMID: 18629460.

2. Ringe JD, Dorst A, Faber H. Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate. Osteoporos Int. 2005; 16:2063–2068. PMID: 16228105.

3. Varenna M, Zucchi F, Binelli L, Failoni S, Gallazzi M, Sinigaglia L. Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone. 2002; 31:96–101. PMID: 12110419.

4. Daniel WW, Sanders PC, Alarcon GS. The early diagnosis of transient osteoporosis by magnetic resonance imaging. A case report. J Bone Joint Surg Am. 1992; 74:1262–1264. PMID: 1400558.

5. Guerra JJ, Steinberg ME. Distinguishing transient osteoporosis from avascular necrosis of the hip. J Bone Joint Surg Am. 1995; 77:616–624. PMID: 7713981.

6. Fabbriciani G, Pirro M, Manfredelli MR, Bianchi M, Sivolella S, Scarponi AM, Mannarino E. Transient osteoporosis of the hip: successful treatment with teriparatide. Rheumatol Int. 2010; 3. 18.

7. Hayes CW, Conway WF, Daniel WW. MR imaging of bone marrow edema pattern: transient osteoporosis, transient bone marrow edema syndrome, or osteonecrosis. Radiographics. 1993; 13:1001–1012. PMID: 8210586.

8. Parker RK, Ross GJ, Urso JA. Transient osteoporosis of the knee. Skeletal Radiol. 1997; 26:306–309. PMID: 9194233.

9. Schapira D, Braun Moscovici Y, Gutierrez G, Nahir AM. Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates. Clin Exp Rheumatol. 2003; 21:107–110. PMID: 12673900.

10. Miyanishi K, Kaminomachi S, Hara T, Maeda H, Watanabe H, Shimizu A, Torisu T. A subchondral fracture in transient osteoporosis of the hip. Skeletal Radiol. 2007; 36:677–680. PMID: 17225152.